DURECT CORP DRRX (NASDAQ) $ 5.28 Change: -0.05 -0.95% | Volume: 158,000

DURECT CORP - Fundamental Profile

Company Information

Ticker Symbol: DRRX
Exchange: NASD
Contact Info: 2 Results Way Cupertino CA 95014 408 777-1417
CEO/President: James E. Brown D.V.M
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.

Share Information

Shares Outstanding: 81,800 (000) Market Value: 435,830 ($000)
Percentage of Inst.Shareholders: 62.47% Number of Inst.Shareholders: 10.00%
Last Quarter Sales: 6.30 ($Mil.) Last Quarter Net Income: -8.60 ($Mil.)
Last Quarter EPS: -0.11 P/E Ratio: 0
Most Recent Earnings: -0.11 on 08/05/08 Earnings Per Share: -0.43
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -19.50 18.51
MERCK CO INC -32.20 34.30
JOHNSON AND JOH +18.40 70.67
SCHERING PLOUGH -28.80 19.26
BRISTOL MYERS S -18.00 21.49